Driving as a Biomarker for Disease*

Date/Time: Monday, September 11, 2023 - 12:00 PM – 1:00 PM
Track: Interactive Lunch Workshop
Room: Franklin Hall 3 (4th Floor)
Log in to Add to My Schedule

Description:

Session Evaluation Form: https://myana.org/form/ana2023-session-evaluation-drivi

Chair: Andrea Schneider, MD, PhD

Co-Chair: Ganesh M. Babulal, PhD, OTD, MSCI, MOT, OTR/L

The goal of this session is to show how changes in driving behaviors can be used a biomarker for evaluating changes seen in multiple neurological disorders including Alzheimer disease, Parkinson's disease, traumatic brain injury/concussion and multiple sclerosis, among others.

Learning Objectives:

  • To gain knowledge about how driving is impacted by various neurological diseases.
  • To learn about different techniques to assess driving function in neurological disease.

Driving and Preclinical Alzheimer’s Disease among older adults

Speaker: Ganesh M. Babulal, PhD, OTD, MSCI, MOT, OTR/L

This talk will examine demographic and clinical risk factors associated with a decline in driving performance and higher crashes among older drivers. We will also discuss the utility of daily driving behavior to screen and identify multimodal changes occurring in preclinical Alzheimer’s disease.

Driving after concussion in adolescents

Speaker: Catherine McDonald, PhD, RN, FAAN

A concussion can affect cognition, concentration, processing speed, and oculomotor function, all critical driving functions. Limited research investigates driving after concussion in adolescents. This presentation reports on an ongoing NIH study examining returning to drive after concussion in adolescents using smartphone-based data and high-fidelity driving simulation. Concussed adolescents ≤28 days of injury and ages 16.5-18 years with a driver’s license were able to enroll in the simulator experiment arm or for those ≤10 days of injury into the on-road arm. All participants downloaded a smartphone ecological momentary assessment tool for concussion (ReCoUPS) to monitor symptoms via the Post-Concussion Symptom Inventory (PCSI). Those enrolled in the simulator arm completed a set of clinical assessments pre- and post- their experimental simulated drives. Those enrolled in the on-road arm downloaded a smartphone application to monitor driving behaviors (Way to Drive). In this presentation, we will report on our preliminary data of daily concussion symptoms, simulated experiments, and on-road driving behaviors (trip frequency, length, duration, speeding, handheld cellphone use, and hard braking) for an initial sample of enrolled participants.

Fitness to Drive Intervention for Young Adults with ASD

Speaker: Anne Dickerson, PhD, OTR/L, SCDCM, FAOTA, FGSA

As a highly complex task of daily living, driving must be considered when there is any diagnosis of of neurological condition, especially for those which are progressive (dementia) or lifelong (autism). As a task that requires functioning vision, perception, motor and especially cognition, determining fitness to drive is a specialized practice. This presentation will highlight current research on determining fitness to drive for those with neurological conditions.


 

 

Speaker(s):